Description
Product Description:
CJC-1295 (no DAC), also referred to as Mod GRF (1-29), is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to mimic the activity of endogenous GHRH while maintaining a shorter half-life due to the absence of Drug Affinity Complex (DAC) modification.In research settings, CJC-1295 (no DAC) has been studied for its interaction with pituitary GHRH receptors, contributing to pulsatile growth hormone signaling and downstream endocrine pathway activity. Its shorter duration of action makes it a useful compound in studies focused on controlled hormone release patterns and receptor dynamics.This peptide is commonly utilized in in vitro and experimental models investigating growth hormone regulation, peptide-receptor interactions, and endocrine system signaling.
Key Features:
Chemical Name: Modified Growth Hormone Releasing Hormone (1-29)
Molecular Formula: C₁₄₉H₂₄₆N₄₄O₄₂
CAS Number: 863288-34-0
Amino Acid Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg (Mod GRF 1-29)
Physical Form: Lyophilized powder
Compound Class: Synthetic peptide / GHRH analog
Purity: ≥98% (HPLC)
Fill Size: 10mg per vial
Storage Conditions: Store at 36–46°F (2–8°C) in a dry, light-protected environment.
Research References:
- Teichman, S. L. et al. (2006). Prolonged stimulation of growth hormone secretion by CJC-1295 in clinical and preclinical models. Journal of Clinical Endocrinology & Metabolism.
- Bowers, C. Y. et al. (1990). Growth hormone-releasing hormone analogs and their activity in endocrine research. Endocrinology.
- Jette, L. et al. (2005). Pharmacological properties of modified GRF (1-29) analogs. Peptides Journal.
Important Notice:
This product is intended for research use only. It is not for human or veterinary use. It is not intended to diagnose, treat, cure, or prevent any disease. Use is restricted to qualified professionals in controlled laboratory environments.
Reviews
There are no reviews yet.